| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10555 | 6480464 | Ethinyl Estradiol results in increased expression of ETS2 mRNA | CTD | PMID:14976129 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:10555 | 6480464 | Ethinyl Estradiol affects the expression of ETS2 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | increases expression | ISO | RGD:1352353 | 6480464 | Estradiol results in increased expression of ETS2 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | affects expression | ISO | RGD:10555 | 6480464 | Estradiol affects the expression of ETS2 mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | decreases expression | ISO | RGD:1352353 | 6480464 | Estradiol results in decreased expression of ETS2 mRNA | CTD | PMID:16474171 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1352353 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ETS2 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1352353 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ETS2 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1352353 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ETS2 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10555 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ETS2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ETS2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ETS2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1352353 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ETS2 mRNA | CTD | PMID:19619570 |
| 2-butoxyethanol | increases expression | ISO | RGD:10555 | 6480464 | n-butoxyethanol results in increased expression of ETS2 mRNA | CTD | PMID:19812364 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | ISO | RGD:1352353 | 6480464 | Am 580 results in increased expression of ETS2 mRNA | CTD | PMID:16982809 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1352353 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of ETS2 mRNA | CTD | PMID:12419474 |
| acetylsalicylic acid | decreases expression | ISO | RGD:1352353 | 6480464 | Aspirin results in decreased expression of ETS2 mRNA | CTD | PMID:20457246 |
| benzo[a]pyrene | increases expression | ISO | RGD:1352353 | 6480464 | Benzo(a)pyrene results in increased expression of ETS2 mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1352353 | 6480464 | Benzo(a)pyrene results in decreased expression of ETS2 mRNA | CTD | PMID:22178795 |
| benzo[a]pyrene | increases expression | ISO | RGD:10555 | 6480464 | Benzo(a)pyrene results in increased expression of ETS2 mRNA | CTD | PMID:21569818 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:10555 | 6480464 | Benzo(a)pyrene results in increased expression of ETS2 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases expression | ISO | RGD:1352353 | 6480464 | Benzo(a)pyrene results in increased expression of ETS2 mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10555 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of ETS2 mRNA | CTD | PMID:21715664 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:10555 | 6480464 | Mustard Gas results in increased expression of ETS2 mRNA | CTD | PMID:15674843 |
| bisphenol A | decreases expression | ISO | RGD:1352353 | 6480464 | bisphenol A results in decreased expression of ETS2 mRNA | CTD | PMID:16474171 |
| cadmium atom | increases expression | ISO | RGD:1352353 | 6480464 | Cadmium results in increased expression of ETS2 mRNA | CTD | PMID:17547211 |
| cadmium dichloride | increases expression | ISO | RGD:1352353 | 6480464 | Cadmium Chloride results in increased expression of ETS2 mRNA | CTD | PMID:17547211 |
| calcitriol | decreases expression | ISO | RGD:1352353 | 6480464 | Calcitriol results in decreased expression of ETS2 mRNA | CTD | PMID:16002434 |
| ciprofibrate | increases expression | ISO | RGD:10555 | 6480464 | ciprofibrate results in increased expression of ETS2 mRNA | CTD | PMID:12771043 |
| cisplatin | increases expression | ISO | RGD:1352353 | 6480464 | Cisplatin results in increased expression of ETS2 mRNA | CTD | PMID:21603599 |
| clofibrate | multiple interactions | ISO | RGD:10555 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ETS2 mRNA; more ... | CTD | PMID:17585979 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of ETS2 mRNA | CTD | PMID:17602206 |
| curcumin | decreases expression | ISO | RGD:1352353 | 6480464 | Curcumin results in decreased expression of ETS2 protein | CTD | PMID:17332326 |
| cyclosporin A | increases expression | ISO | RGD:1352353 | 6480464 | Cyclosporine results in increased expression of ETS2 mRNA | CTD | PMID:20106945 |
| dexamethasone | increases expression | ISO | RGD:1352353 | 6480464 | Dexamethasone results in increased expression of ETS2 mRNA; more ... | CTD | PMID:12732289 |
| diarsenic trioxide | increases expression | ISO | RGD:1352353 | 6480464 | arsenic trioxide results in increased expression of ETS2 mRNA | CTD | PMID:20458559 |
| dibutyl phthalate | increases expression | ISO | RGD:10555 | 6480464 | Dibutyl Phthalate results in increased expression of ETS2 mRNA | CTD | PMID:21266533 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of ETS2 mRNA | CTD | PMID:21551480 |
| folic acid | affects expression | ISO | RGD:1352353 | 6480464 | Folic Acid affects the expression of ETS2 mRNA | CTD | PMID:16361273 |
| formaldehyde | increases expression | ISO | RGD:1352353 | 6480464 | Formaldehyde results in increased expression of ETS2 mRNA | CTD | PMID:20655997 |
| genistein | decreases expression | ISO | RGD:1352353 | 6480464 | Genistein results in decreased expression of ETS2 mRNA | CTD | PMID:16474171 |
| hydrogen peroxide | affects expression | ISO | RGD:1352353 | 6480464 | Hydrogen Peroxide affects the expression of ETS2 mRNA | CTD | PMID:20044591 |
| menadione | affects expression | ISO | RGD:1352353 | 6480464 | Vitamin K 3 affects the expression of ETS2 mRNA | CTD | PMID:20044591 |
| mercury atom | increases expression | ISO | RGD:1352353 | 6480464 | Mercury results in increased expression of ETS2 mRNA | CTD | PMID:17547211 |
| mercury(0) | increases expression | ISO | RGD:1352353 | 6480464 | Mercury results in increased expression of ETS2 mRNA | CTD | PMID:17547211 |
| N-nitrosodiethylamine | affects expression | ISO | RGD:10555 | 6480464 | Diethylnitrosamine affects the expression of ETS2 mRNA | CTD | PMID:21159647 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10555 | 6480464 | Diethylnitrosamine results in increased expression of ETS2 mRNA | CTD | PMID:12771043 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:1352353 | 6480464 | Dimethylnitrosamine results in increased expression of ETS2 mRNA | CTD | PMID:17547211 |
| nickel atom | increases expression | ISO | RGD:1352353 | 6480464 | Nickel results in increased expression of ETS2 mRNA | CTD | PMID:21054559 |
| nickel sulfate | increases expression | ISO | RGD:1352353 | 6480464 | nickel sulfate results in increased expression of ETS2 mRNA | CTD | PMID:16780908 |
| nickel sulfate | increases expression | ISO | RGD:1352353 | 6480464 | nickel sulfate results in increased expression of ETS2 mRNA | CTD | PMID:18651567 PMID:16780908 |
| nickel sulfate | increases expression | ISO | RGD:1352353 | 6480464 | nickel sulfate results in increased expression of ETS2 mRNA | CTD | PMID:16780908 PMID:18651567 |
| paracetamol | multiple interactions | ISO | RGD:10555 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ETS2 mRNA] | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:1352353 | 6480464 | Acetaminophen results in decreased expression of ETS2 mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:10555 | 6480464 | Acetaminophen affects the expression of ETS2 mRNA | CTD | PMID:17562736 |
| phenobarbital | multiple interactions | ISO | RGD:10555 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ETS2 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:10555 | 6480464 | Phenobarbital results in increased expression of ETS2 mRNA | CTD | PMID:19482888 |
| phenol | increases expression | ISO | RGD:1352353 | 6480464 | Phenol results in increased expression of ETS2 mRNA | CTD | PMID:17547211 |
| pirinixic acid | multiple interactions | ISO | RGD:10555 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ETS2 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:10555 | 6480464 | pirinixic acid results in increased expression of ETS2 mRNA | CTD | PMID:18445702 PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:10555 | 6480464 | pirinixic acid results in increased expression of ETS2 mRNA | CTD | PMID:18301758 PMID:18445702 |
| retinyl acetate | increases expression | ISO | RGD:10555 | 6480464 | retinol acetate results in increased expression of ETS2 mRNA | CTD | PMID:16772331 |
| rosiglitazone | increases expression | ISO | RGD:1352353 | 6480464 | rosiglitazone results in increased expression of ETS2 mRNA | CTD | PMID:16982809 |
| succimer | multiple interactions | ISO | RGD:10555 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ETS2 mRNA | CTD | PMID:21641980 |
| tamoxifen | affects expression | ISO | RGD:10555 | 6480464 | Tamoxifen affects the expression of ETS2 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1352353 | 6480464 | tert-Butylhydroperoxide results in decreased expression of ETS2 mRNA | CTD | PMID:12419474 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1352353 | 6480464 | tert-Butylhydroperoxide results in increased expression of ETS2 mRNA | CTD | PMID:15336504 |
| tetrachloromethane | decreases expression | ISO | RGD:10555 | 6480464 | Carbon Tetrachloride results in decreased expression of ETS2 mRNA | CTD | PMID:17484886 |
| vancomycin | decreases expression | ISO | RGD:10555 | 6480464 | Vancomycin results in decreased expression of ETS2 mRNA | CTD | PMID:18930951 |
| zinc atom | multiple interactions | ISO | RGD:1352353 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ETS2 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1352353 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ETS2 mRNA | CTD | PMID:18593933 |